Tower Research Capital (TRC)’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22K | Buy |
4,159
+2,712
| +187% | +$14.3K | ﹤0.01% | 3626 |
|
|
2025
Q1 | $11.8K | Sell |
1,447
-277
| -16% | -$2.26K | ﹤0.01% | 3505 |
|
|
2024
Q4 | $22.1K | Buy |
1,724
+271
| +19% | +$3.47K | ﹤0.01% | 3112 |
|
|
2024
Q3 | $15.6K | Sell |
1,453
-3,548
| -71% | -$38K | ﹤0.01% | 3407 |
|
|
2024
Q2 | $39.6K | Buy |
5,001
+4,753
| +1,917% | +$37.6K | ﹤0.01% | 3273 |
|
|
2024
Q1 | $3.98K | Sell |
248
-7,097
| -97% | -$114K | ﹤0.01% | 4760 |
|
|
2023
Q4 | $101K | Buy |
7,345
+6,797
| +1,240% | +$93.3K | ﹤0.01% | 2640 |
|
|
2023
Q3 | $8.01K | Sell |
548
-76
| -12% | -$1.11K | ﹤0.01% | 4408 |
|
|
2023
Q2 | $10.6K | Buy |
+624
| New | +$10.6K | ﹤0.01% | 4070 |
|
|
2023
Q1 | – | Sell |
-3,464
| Closed | -$23K | – | 6194 |
|
|
2022
Q4 | $23K | Buy |
3,464
+1,845
| +114% | +$12.3K | ﹤0.01% | 3003 |
|
|
2022
Q3 | $9K | Sell |
1,619
-9,774
| -86% | -$54.3K | ﹤0.01% | 4682 |
|
|
2022
Q2 | $54K | Buy |
11,393
+10,415
| +1,065% | +$49.4K | ﹤0.01% | 2809 |
|
|
2022
Q1 | $8K | Sell |
978
-943
| -49% | -$7.71K | ﹤0.01% | 4611 |
|
|
2021
Q4 | $23K | Sell |
1,921
-1,341
| -41% | -$16.1K | ﹤0.01% | 3524 |
|
|
2021
Q3 | $58K | Buy |
3,262
+2,183
| +202% | +$38.8K | ﹤0.01% | 2829 |
|
|
2021
Q2 | $22K | Buy |
+1,079
| New | +$22K | ﹤0.01% | 3812 |
|
|
2021
Q1 | – | Sell |
-654
| Closed | -$12K | – | 5660 |
|
|
2020
Q4 | $12K | Sell |
654
-1,044
| -61% | -$19.2K | ﹤0.01% | 4209 |
|
|
2020
Q3 | $43K | Buy |
1,698
+1,422
| +515% | +$36K | ﹤0.01% | 3597 |
|
|
2020
Q2 | $8K | Buy |
+276
| New | +$8K | ﹤0.01% | 4117 |
|